+971 50 696 8166

MARKETS | CUSTOMERS

Our technology serves thousands of patients across 50+ hospitals in 3 countries, helping them efficiently manage and control their health on a daily basis

We integrate medical devices and smart devices with remote monitoring systems and Electronic Health Record (EHR)

Our innovative tools streamline referrals, reducing wait times and enhancing communication

15 regions and countries

Andalucía
C. Valenciana
Cataluña
C. Madrid
Castilla y León
País Vasco
Cantabria
Aragón
R. Murcia
Galicia
Extremadura
Portugal
Poland
Belgium
Peru

+ 50 hospitals & societies

SCIENTIFIC SOCIETIES
SEOM (Oncology)
SEFH (Pharmacy)
SEC (Cardiology)
SVR (Rheumatology)

MADRID
Hospitals: La Paz, Gregorio Marañón, Ramón y Cajal, 12 de Octubre, Puerta de Hierro, Clínico San Carlos, Fuenlabrada, Getafe, Alcorcón

CATALUÑA

Hospitals: Sant Pau, Clinic BCN, Vall d´Hebrón, Bellvitge, Tauli – Sabadell, CST Tarrassa, San Rafael

ICO – Oncology

VALENCIA Y MURCIA

Hospitals: La Fe, Clínico, Alzira, Arnau de Vilanova, Clínica Benidorm, Provincial CS, Morales Meseguer, Virgen de la Arrixaca, Virgen de Caridad, Virgen Rosell

IVO

OTHER REGIONS

Hospitals: Galdakao (Euskadi), Marqués de Valdecilla (Cantabria), Virgen de las Nieves (Granada), Miguel Servet (Zaragoza), San Pedro de Alcántara (Cáceres), El Ferrol (Galicia)

MULTICENTRE

EII (14 Hosp.)
Colorectal cancer (30 Hosp.)
Anticoagulants Murcia (6 Hosp)
Appointments – Castilla y León (14 Hosp.)
NISA – VITHAS (8 Hosp.)

+ 10 THERAPEUTIC AREAS

PNEUMOLOGY
ONCOLOGY & HAEMATOLOGY
ENDOCRINE & DIGESTIVE
PAEDIATRICS & ADOLESCENCE
CARDIOLOGY
NEUROLOGY
HOSPITAL PHARMACY
Pluripathological Patient
Oncology Oral antineoplastics

OTHER SPECIALITIES
Rheumatology: Rheumatoid arthritis + Juvenile idiopathic arthritis + Psoriatic arthritis
Dermatology: Psoriasis
Infectious diseases: HIV, HCV
Nephrology: Peritoneal dialysis

DIGITISATION OF HOSPITAL PROCESSES
Home monitoring
Paediatric ICU
Emergency
Post-surgical

+ 40 diseases

Endocrine & Digestive

Diabetes mellitus II
IBD – Ulcerative colitis
IBD – Crohn’s disease
Growth hormone

Pneumology

Sleep apnoea
Asthma
COPD
Cystic fibrosis
Pulmonary hypertension
Smoking

Pediatrics & Adolescence

Diabetes mellitus I
Childhood asthma
Neonates / Premature
Childhood obesity
Eating disorders
Attention deficit disorders
Autism spectrum disorders

Oncology & Hematology

Anticoagulation
Haemophilia
Multiple myeloma
Myelodysplastic syndrome
Chronic myeloid leukaemia
Chronic lymphatic leukaemia
Colorectal cancer
Breast cancer
Lung cancer

Endocrine & Digestive

Rheumatology. Rheumatoid arthritis
Rheumat. Juvenile idiopathic arthritis
Rheumatology. Psoriatic arthritis
Dermatology. Psoriasis
Infectious diseases. HIV/HCV
Traumatology. Osteoporosis & hip fracture
Pregnancy. Deep venous thrombosis
Gynaecology. Endometriosis

Cardiology

Heart failure
Acute coronary syndrome
Heart transplant

Neurology

Epilepsy
Alzheimer’s
Parkinson’s disease
Multiple sclerosis
Amyotrophic lateral sclerosis

Hospital Pharmacy

Pluripathological patient
Oncology. Oral antineoplastics

Other Assistance Processes

Home Hospitalization
Paediatric ICU
Post-surgical follow-up
Emergencies for Nursing Homes

trilema middle east

LABORATORIES | PHARMAS

AMGEN

Since 2018, the Trilema Group has had a strategic collaboration agreement with this multinational pharmaceutical company.

Amgen started its activity in Spain in 1990 to become the leading biopharmaceutical company in the country. Currently, it has nearly 80 clinical trials underway in different therapeutic areas.

The alliance with AMGEN focuses on the development of care innovation and patient empowerment with the adaptation of movisalud technology for the therapeutic areas of Oncohematology, Cardiology and Hospital Pharmacy.

Abbvie (Abbott)

  • National scope.
  • Digestive services project in 10 hospitals.
  • Management of patients with inflammatory bowel diseases.

Allergan and network of private clinics (dermatological treatments)

  • Design of the project for post-surgical monitoring of patients treated with botox®.

Astellas Pharma

  • With the Transplant Unit of the Hospital Sant Pau in Barcelona.
  • Management of heart transplant patients (led by pharmacy and cardiology).

AstraZéneca

  • With the cardiology service of the Fuenlabrada and Getafe hospitals.
  • Management of patients with heart failure and post-infarction in the rehabilitation phase.

Bayer Hispania

  • With the Spanish Society of Medical Oncology: breast cancer patients (national multihospital level).
  • With Dep. Pneumology at Hosp.Clínic de Barcelona: patients with pulmonary hypertension.

Biogen Idec

  • With the Pharmacy Service of the Hospital Virgen de las Nieves (Granada).
  • Management of patients with multiple sclerosis.

Bristol-Myers Squibb

  • Product management Orencia®.
  • Designing a platform for the management of patients with rheumatoid arthritis

Celgene

  • Management of blood products (Vidaza® y Revlimid®).
  • Design of patient management platform with SDM and MM.

Danone Spain

  • WithEcosysteme (France) y 15 schools.
  • Early Childhood Education Project.
  • Holistic model for the development of holistic health in the classroom

Janssen Cilag

  • Infectious diseases – HIV/HCV (national project).
  • Self-monitoring and follow-up of patients with HIV and HCV (AIDS and hepatitis C).

Novartis

  • With Hospital Vall d’Hebron in Barcelona.
  • Management of paediatric patients with asthma (Premio Hinnovar 2014).

Novo Nordisk

  • With pharmacy service of the Hosp. La Fe de Valencia: paediatric patients with growth hormone deficiency.
  • With endocrinology of Hosp. Fuenlabrada: management of the evolutionary consultation (patients with type 2 diabetes mellitus).

Nutricia Nestlé España

  • With the paediatrics service of the Hospital Clínico de Valencia.
  • Developmental management of paediatric patients with obesity problems.

Oximesa

  • With the Pneumology Service of the Marqués de Valdecilla Hospital.
  • Telecontrol Self-Control Project for COPD patients.

Pfizer

With Pharmacy Service Hosp. La Fe: clinical trial for batch control, expiry and traceability of the cold chain in the home of the patient with biologic therapies (rheumatoid arthritis).

With the Haematology Service of Hosp. La Paz: prescription and dispensing management solution for haemophilia patients.

Siemens Health

  • Laboratory Division.
  • Development of BI software for laboratory management.
  • Laboratory analyser interoperability platform development

 

Teva Pharma

  • With the pharmacy service of Hospital Miguel Servet (Zaragoza).
  • Management and follow-up of patients with multiple sclerosis.

UCB Pharma

  • With the Neurology Service of the Hospital de Torrevieja.
  • Pilot management of patients with epilepsy.

Werfern Group(IZASA)

  • With Hospital Morales Meseguer.
  • Management of patients with OAT (oral anticoagulant therapy).

TECHNOLOGICAL PROJECTS

Ballesol, senescence's talent

Ballesol, senescence's talent

Start date: 2020

Pedagogical and technological tools to complement and enrich the current programmes for the development of cognitive activity in the elderly who live at Ballesol or attend its Day Care Centres, both for those who are valid and those who are assisted.

We also strengthen a new scenario of relationship and communication with the family of the residents trying to value the effort that is being made in care therapy and capitalizing on a solid model of social innovation of the Residencias Ballesol.

READ ARTICLE
SACYL, Hospital appointments

SACYL, Hospital appointments

Start dates: 2016

We manage the delivery of millions of specialized care appointments through our notification infrastructures and reminder management to patients in Castilla León (services hosted on servers of the Regional Health Management).

SACYL patients receive notices on their mobile about assignments, changes or cancellations of outpatient visits with their doctors in the 14 public hospitals in the region.

ACTIVEHIP+ eitHealth

ACTIVEHIP+ eitHealth

Start date: 2020

The patient who has suffered a hip fracture has a powerful program of monitoring his Rehabilitation Plan in twelve weeks. It has hundreds of videos and support questionnaires associated with the different rehabilitation sessions.

Project specially designed to help the tutors and relatives of elderly patients who suffer a hip fracture.

Project developed by Trilema and framed in the European innovation program eitHeath for Hosp.Virgen de las Nieves. It has the collaboration and participation of the SAS (Andalusian health service), University of Barcelona, University of Lisbon, Hospital Center of Northern Lisbon, AMGEN.

NICEBEATS + eitHealth

NICEBEATS + eitHealth

Start date: 2019

The patient with heart failure who has suffered a significant decompensation is hospitalized between 8 and 10 days. From the hospital bed and during those days of admission, “nicebeats” or “good heartbeats” (cotelhf) help the patient to better understand their disease and, especially, to manage prevention or reaction to future decompensations.

A content program led by the medical team of the Hospital Clinic de Barcelona structures the self-management of the IC into 17 thematic blocks loaded with audio-visual production. Nurses assign a plan to each patient based on their risk factors at the time of admission.

Project developed by Trilema and framed in the European innovation program eitHeath. It has the collaboration and participation of the Hospital Clinic, the University of Barcelona, the University of Lisbon and AMGEN.

ONCOMMUN+ eitHealth

ONCOMMUN+ eitHealth

Star date: 2018

OnCommun is the most powerful initiative in Europe in the digital integration of the Psychosocial Care and Health Education services in the world of Cancer. It is an extension of the ICOnnecta project to a multi-country environment (Spain, Portugal and Poland), also related to PsicoOncología Online.

It has online solutions based on a staggered intervention program for cancer patients. Depending on their needs, the symptoms and the emotional state detected, the patient can receive a more intensive and personalized health education and psychosocial care.

Healthcare technology, app, videoconference, eLearning, social network, wearables together with a multidisciplinary team, make up a successful initiative.

Trilema contributes the adaptation of movisalud to the psychosocial profile of the cancer patient. Project framed in the European innovation program eitHeath and led by the Catalan Institute of Oncology (ICO) with the collaboration and participation of the Health Department of the Generalitat de Catalunya, IDIBELL, Instituto Pedro Nunes, University of Barcelona, Nofer Institute of occupational Medicine of Poland and AMGEN.

EMMA PLATFORM + eitHealth

EMMA PLATFORM + eitHealth

Start date: 2019

EMMA is a healthcare platform, based on the movisalud model, which Trilema has adapted for the company AMGEN and which allows it to integrate in a single access environment all the vertical initiatives or applications that the company has launched in recent years.

It has a higher priority focus on the therapeutic areas of Cardiology and Oncohematology, as well as innovative solutions for hospital pharmacies.

AMGEN incorporates into EMMA its new vertical applications MYPlan, Myeloma o CardioPlan, but it has also integrated some tools already existing in the market, such as mHeart o eOncoSalud, which had been orphaned by by institutional support or lacked support for their continuity.

EMMA CardioPlan

EMMA CardioPlan

Start date: 2018

Rehabilitation Programme after Coronary Syndrome. The patient who has suffered an ACS (acute coronary syndrome) must start a cardiac rehabilitation process where exercise, feeding and control of their cardiac biomedical measures will be key to a successful recovery.

Trilema develops for AMGEN a new environment of movisalud called “CardioPlan” that aims to help patients with various heart diseases to transform their lifestyle and participate in managing their health. Cardiologists and nurses have remote monitoring and control of their evolution. Implanted in its beginnings in Hospital Arnau de Vilanova y Hospital La Fe de Valencia.

The projects SCAchart“ de Baleares y “RC” from the Balearic Islands and the Valencian Community are immersed in the Cardioplan family of applications.

       

EMMA MYeloma

EMMA MYeloma

Start date: 2019

Illusive improvements recently observed in the survival of the patient with multiple myeloma reflect advances in the approach of the different stages of cancer care: early detection, early diagnosis, agility in diagnosis, as well as advances in treatments and research.

AMGEN launches “MYeloma”, a new variant of the EMMA platform specialised in the management and control of oncohaematological patients, which also includes a powerful self-care and symptom management protocol. This version also incorporates a visual prescription and pharmacological control chart for treatments subject to cycles and breaks.

At a scientific level, the project has been designed at the Sant Pau hospital with the collaboration of multidisciplinary teams at the Gregorio Marañón Hospital in Madrid and the Hospital Clinic in Barcelona.

EMMA MYplan

EMMA MYplan

Date: 2018

In the current healthcare context, it is necessary to have clinical support tools that allow healthcare professionals to efficiently control and manage the treatment and illness of patients.

The MYplan tool involves the patient in the management and evolution of their health, providing preventive and health promotion content, recommendations, systems for recording their evolutionary status, their episodes or symptoms, as well as, in a special way , help tools and validation of compliance with your treatments.

MYPLAN is integrated as the first healthcare step, impacting significantly on the structural costs of healthcare system care and its future sustainability.

It was born under the scientific design of the staff of the pharmacy service of the Hospital Clinic of Barcelona, the technological development of the Trilema Foundation and all the institutional support of AMGEN.

EMMA mHeart

EMMA mHeart

Date: 2016

Heart Transplant Patients. Lack of adherence to immunosuppressive medications after organ transplantation ranges from 20 to 40% and is associated with episodes of acute rejection and graft loss.

This fact justifies the design and implementation of multidisciplinary interventions to improve therapy management where patient empowerment is key.

The mHeart initiative, led by Mar Gomis from the Hospital Sant Pau pharmacy service, is an adaptation of movisalud aimed at facilitating communication with the patient and recording the timing of drug intake, drug interactions, vital signs, effects Side effects and symptoms. T

The effectiveness of the pharmaceutical interventions implemented through the mHeart tool was high: 83% of the non-adherent recipients at the first visit became adherent at the end of the study according to the SMAQ test.

EMMA eOncoSalud

EMMA eOncoSalud

Date: 2018

For the Oncology Patient with Antineoplastic Treatment, eOncoSalud is an application created by the Pharmacy Service of the Gregorio Marañón Hospital to improve communication between the hospital pharmacist and cancer patients undergoing oral treatment.

The App contains information about their treatment, diary, patient progress log and advice, as well as real-time reporting of adverse events, i.e. sending messages to patients, thus avoiding patients having to go to the emergency room.

By February 2022, more than 400 cancer patients had already used it.

EMMA eFarMcuida

EMMA eFarMcuida

Date: 2020

This project is an adaptation on “mHeart”, personalized at the branding level for the Gregorio Marañón Hospital in Madrid, which allows monitoring of the heart transplant patient.

The pharmacy service of this Hospital is incorporating a map of applications where the self-care plan is customized to the specific needs of each disease.

After eOncoSalud and the recently released “eFarMcuida”, the service is preparing to launch a new initiative for 2020 in patients with psoriasis, psoriatic arthritis and / or ankylosing spondylitis.

EntrenaEII, telemonitoring and self-control

EntrenaEII, telemonitoring and self-control

Date: 2016

Dr. Ana Echarri Piudo, specialist in the digestive system and head of the Inflammatory Bowel Disease (IBD) Unit at the Ferrol University Hospital Complex (CHUF), invited us to participate in the “EducaInflammatory” project in 2016. With his scientific contribution and the support of Abbvie and the ISCIII, we have managed to develop Movisalud’s technology to a much more powerful level of care in 18 hospitals in Spain for digestive pathology units (Colitis and Crohn’s disease).

The publication of the results of the “MediCrohn” study, conducted in 14 hospitals between 2016 and 2017, is available and concludes with:

“We found a high percentage of agreement between patients’ self-administered mobile app HBI and in-clinic physician assessment to detect CD activity with a remarkably high PPV for remission. The mobile app HBI might allow a strict control of inflammation by remote monitoring and flexible follow-up of CD patients. Reduction of sanitary costs could be possible.

ePrematur, monitoring of newborns

ePrematur, monitoring of newborns

Start date: 2017

At the request of the Vall d’Hebron Research Institute (VHIR) foundation and led by the researcher Elisenda Rull, we built in 2016 and 2017 an environment for home monitoring of premature babies after discharge.

The project aimed to measure the baby’s health outcomes by anticipating discharge from the neonatology unit 24h.

The results were surprising (“ePrematur study”), not only in the efficiency of healthcare costs, but also in the evolution of babies’ weight gain when they were together with their mother. The parents’ satisfaction with the project was very exciting for us, many of them asked us to continue using the application despite having finished the study and that their baby was already several weeks old.

Fluye, healthy lifestyle

Fluye, healthy lifestyle

Date: 2020

Project framed in the movement “Feeding the Change”, an initiative of the Ashoka Foundation and the Danone group to fight against childhood obesity that aims to impact more than two million children.

Trilema Zamora among the top 10 schools in the world thanks to Fluye!

The Trilema Foundation leads this action in the school environment with “Fluye”, a whole world of materials and activities in the classrooms for children between 2 and 12 years old. It began with a follow-up study of more than 2,000 children.

Movisalud is responsible for the technological development of the research study associated with the school project that is led by the GENUD of the University of Zaragoza.

Visit website

La Meva Documentació - Parc Taulí

La Meva Documentació - Parc Taulí

Date: 2018

LMD allows to improve the cycle of request for clinical information by the patient, reducing management times and operating costs.

A platform with responsive web access has been developed that allows autonomously requesting clinical information from a patient and that incorporates powerful control and monitoring tools for the clinical documentation and / or patient care service professional.

In the Consorci Corporació Sanitària Parc Taulí de Sabadell, nearly 40,000 requests for clinical documentation were generated annually by patients (discharge reports, emergency reports, laboratory tests, etc.). The project proposes to substantially reduce the number of face-to-face requests for documentation, impacting the cost structure of personnel resources and improving patient service under online delivery mechanisms. Likewise, costs are reduced, both for stationery, printing and physical media such as USB’s, CD’s / DVD’s.

Manejo del Asma Infantil con "Lolo"

Manejo del Asma Infantil con "Lolo"

Date: 2016

Asthma is the main chronic disease in childhood and affects nearly one million children under the age of 18 in Spain.

Under the scientific direction of Dr. Antonio Moreno, from the Pediatrics Service of the Hospital Universitari Vall d’Hebron, we adapt movisalud to the European plan for Childhood Asthma.

In addition to symptomatic control, crisis management or self-assessment and control tools, “Lolo” was born, a character who accompanied children and gamified technology. Lolo, a nice cartoon bubble, came to life to facilitate the participation of the little ones in the management of crises and in the control of their decompensations.

The project was recognized with the Hinnovar award given annually by the Novartis company.

RC, Rehabilitación Cardiaca tras SCA

RC, Rehabilitación Cardiaca tras SCA

Date: 2019

Dr. Ernesto Dallí, cardiologist at the Arnau de Vilanova Hospital in Valencia is leading the RC project, a Comprehensive TeleRehabilitation system whose main purpose is the administration of cardiac rehabilitation therapies based on physical exercise in patients with ischemic heart disease, as well as the provision of content educational and motivational that allow the patient to increase their awareness about their state of health.

Medical professionals involved in the CR process have the possibility to prescribe a physical activity program based on personal training profiles.

The patient must be able to carry out physical activity according to the doctor’s prescription through the help of a guidance and assistance system, which monitors their vital signs and the intensity of the activity carried out, so that it is carried out safely, at all times.

Salud en casa, isolation COVID-19

Salud en casa, isolation COVID-19

Date: 2019

The “Salud en Casa” project is committed to improving the safety of our health professionals and the efficiency of our hospital resources, providing a more sustainable scenario in the absence of available beds in the COVID pandemic.

Movisalud adapts to the WHO protocol for coronaviruses and encourages a massive deployment of self-monitoring in isolation with”remote home care”. The patient has a self-monitoring App, a pulse oximeter, a sphygmomanometer and a training and support service for exhaustive self-care for 14 days.

The program provides variables for fever control and active symptoms every day, in addition to the results in the measurement of oxygen saturation, respiratory rate, blood pressure or pulse.

In addition to decongesting our hospitals, “home health” incorporates a remote monitoring environment, safer for our professionals, where the primary care nurse accesses a powerful surveillance system equipped with control signals that warn of potential risk situations.

“Movisalud has created a telemedicine environment that facilitates the home care strategy during the pandemic” .

We launched this initiative in the Central Region of Portugal (ARSC – Administração Regional de Saúde do Centro), hand in hand with the Ministry of Health and the Pedro Nunes Institute, with several primary care centers linked to the assistance area of the University Hospital of Coimbra.

The ICO, Institut Catalá d’Oncología, has also joined in Spain for home monitoring of a large group of COVID positive cancer patients.

READ NEWS

SCAchart, territorial registry

SCAchart, territorial registry

Date: 2019

Adaptation of movisalud that allows the registration of patient data regarding the use of drugs of the iPSCK9 type (anonymous record structured by case number).

The initiative was born from the Balearic Society of Cardiology. In the project, led by Dr. Alberto Pérez Castellanos, the cardiology services of the Son Espasses and Manacor hospitals in the Balearic Islands participate, with the idea of expanding it to the rest of the region.

The generation of a territorial registry of cases that have suffered an Acute Coronary Syndrome will allow to develop studies about the results and evolution in patients treated with this type of drugs.

It is an initiative supported by AMGEN.

STIcare, digital newspaper on mobile

STIcare, digital newspaper on mobile

Date: 2016

Vertical development carried out for Bayer on IOS and Android for cancer patients treated with the drug stivarga®.

We did not use the healthcare platform in this project as the functional requirements demanded a separate environment for the patient.

STIcare allowed to manage an agenda with the programmed medication, the validation of feedings and the pattern of periodic controls, such as fever, weight or cardiomedidas.

The user could generate a complete report of their history and send it to share it with their doctor. (currently the application is no longer operational in stores).

ControlaTAO, PT/INR testing on mobile

ControlaTAO, PT/INR testing on mobile

Date: 2014

About 900 thousand patients in Spain are medicated with anticoagulant treatments, usually known as Sintrom, Warfarin.

Together with the Izasa team, now the Werfen group, we developed and integrated with them the application that delivers the TAO sheet to patients’ mobile phones. A perfect formula to avoid recurring visits to the health center.

We also integrate and automate the results of the microINR coagulometer in the App.

PsicoOncología Online

PsicoOncología Online

Date: 2014

PsicoOncologiaOnline is a research and innovation group in cancer and digital health.

They investigate how the application of New Information and Communication Technologies can help to reduce the impact of cancer from different fields and disciplines, with a special focus on the psycho-oncological and psychosocial fields.

This project demonstrates how online access to psychological treatments can overcome difficulties for cancer patients, are a cheaper and more accessible alternative to face-to-face therapies, and are just as effective. Related to ICOnnecta and OnCommun.

BioInformatics Barcelona

BioInformatics Barcelona

Date: 2021

Bioinformatics Barcelona (BIB) is a highly specialised bioinformatics ecosystem made up of more than 70 institutions. We promote bioinformatics through the promotion of specialised training, support for advanced research and the transfer of knowledge and technology to society, stimulating competitiveness and industrial innovation.

Specialised training and advanced training courses have been created for professionals focused on all areas of bioinformatics, from programming, data ethics or the application of Big Data in the healthcare field.

PaiNEd

PaiNEd

Date: 2022

Creation of an educational platform and an APP to identify pain in patients. Monitoring is done through a series of tests together with a physiotherapist and the results are analysed.

Hábitos saludables en comedores escolares. Healthy habits in school canteens

Hábitos saludables en comedores escolares. Healthy habits in school canteens

Date: 2020

Creation of an expert course to make the best food practices available to all, backed by research advances.

The school monitor is a key figure in helping children acquire lifestyle habits that contribute to their physical, emotional and social well-being. That is why we want to raise awareness of the broader health and food safety context to help incorporate it into children’s lives and prevent obesity and other health problems.

Dining time is a golden time to teach healthy habits. We try to propose alternatives and behavioural guidelines to enhance communication skills, strengthen personalised attention and trust, and work in a structured way on the relationships between the pupils and the educator.

It is essential to improve communication with families and teachers in order to work together in the acquisition of healthy habits and wellbeing of the pupil.

Protect Your Life, Cuida Tu Salud

Protect Your Life, Cuida Tu Salud

Date: 2020

#CuidaTuSalud -ProtectUrLife is a European project that aims to raise awareness of the importance of promoting healthy ageing, especially from the age of 65 onwards.

From a validated scientific approach, they provide information on two types of diseases: cardiovascular and bone diseases. What do we need to take into account in order to prevent them? Advice and access to educational materials are provided to facilitate behavioural change towards healthier lifestyles.

ICOnnecta

ICOnnecta

Date: 2019

The ICOnnecta’t application, developed for the Institut Català d’Oncologia (ICO), connects and facilitates communication between patients and their healthcare professionals with the aim of reducing the impact of cancer, increasing well-being and quality of life during the patient’s follow-up and ongoing care, as well as providing health education and complementing the accompaniment and psychosocial support of people with cancer during primary oncological or haematological treatments.

Periodically, the application asks the patient to answer questions about his or her physical and emotional state. Health professionals will then be able to contact the patient via messages, with the aim of addressing their health and psychosocial needs and thus trying to improve their well-being. In addition, the app will allow you to record symptoms secondary to cancer or haematological treatment, guiding you in how to self-manage them through health education advice.

In no case is it an emergency service, nor does it replace the face-to-face visits of the ICO’s usual hospital circuit.

Related with PsicoOncologíaOnline and OnCommun. Deployed throughout the Oncology Institute of Catalonia.

Continuing Care AUNA PERU

Continuing Care AUNA PERU

Date: 2020

Application for monitoring oncology patients with various functionalities: AGENDA in daily and monthly format, which alerts you of scheduled tasks and allows you to record your activity (medication intake, controls and appointments); DRUG TREATMENT MANAGER to plan and validate the intake of drugs at each moment, being able to add other drugs and treatments; periodic SELF-CONTROL; REGISTRATION OF SYMPTOMS and ADVERSE EFFECTS; COMMUNICATIONS between patient-professional through internal messages.

All the information entered in the application is recorded in a cloud space called “personal folder”, hosted on secure servers and accessible via the web both by the user -patient- and by his or her authorised professional or doctor.

Talento de la Senectud

Talento de la Senectud

Date: 2022

The Talent of Senescence, Humanisation of care from telecare: is an innovative and technological VET training programme in Nursing and Dependency Aide.

Do you want to know more? Click here.